Zacks Research Issues Optimistic Estimate for FOLD Earnings
Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) - Equities research analysts at Zacks Research boosted their Q1 2026 earnings per share estimates for Amicus Therapeutics in a research report issued to clients and investors on Tuesday, April 1st. Zacks Research analyst R. Department now expe.
Publicado el: 2025-04-03 10:18:09
Autor: lulegacy, Fuente: lulegacy
Compartir: 
